Here's Why Hold Strategy is Apt for CME Group (CME) Stock

The Zacks Consensus Estimate for CME Group's 2024 earnings per share indicates a year-over-year increase of 4%. The consensus estimate for revenues is pegged at $5.90 billion, implying a year-over-year improvement of 5.8%. Growth Projections Currently, the long-term earnings growth rate is 3.9%. The Zacks Consensus Estimate for CME's 2024 and 2025 earnings has moved 1.7% and 1.7% north, respectively, in the past 60 days. This should instill investors' confidence in the stock. CME Group has a decent earnings ...